Replies to post #1054 on Phio Pharmaceuticals Corp (PHIO)

[Steuvin]

Fully diluted it is about 36 million. The common underlying the convertible preferreds alone is 23 million post-split.

Still, this is a good buy. GURU at Nasdaq has one year target of 12.

http://www.nasdaq.com/symbol/rxiid